HiGenoMB®- HiMedia Proudly Announces CE-IVD Approval Received for Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262)

 

HiGenoMB®- HiMedia Proudly Announces CE-IVD Approval Received for Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262)

Press Release

HiGenoMB®- HiMedia Proudly Announces CE-IVD Approval Received for Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262)

Jai Prakash

HiGenoMB®- HiMedia Proudly Announces CE-IVD Approval Received for Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262)

HiGenoMB® Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the pioneers in Indian BioSciences manufacturing segment adds another feather in the cap with their newly CE/IVD approved Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262).

Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19. Hi-PCR® COVID-FLU Multiplex Probe PCR Kit, is a multiplex PCR kit that can differentiate between COVID-19 and Flu using a single tube reaction.

It is recommended for sensitive and specific detection of SARS-CoV-2 and Influenza virus in clinical samples. Targets include RdRp gene of SARS-CoV-2 virus, Influenza A virus (Swine flu 2009 H1N1 virus, seasonal H3N2 & seasonal H1N1), Influenza B virus and Internal control (IC)

Covid-19 pandemic has impacted millions of lives globally. The symptoms are similar to those of influenza, both being contagious respiratory illness. As the public's concern of contracting Covid-19 continued to rise, flu symptoms were frequently mistaken for those of Covid-19.

Performing separate tests for detection of Covid-19 and Influenza can be time consuming, costly & a cumbersome affair. HiMedia’s MBPCR262 being a multiplex kit eliminates the need for separate tests thereby significantly reducing the time & resources.

Dr. Kavita Khadke, Director of HiMedia’s Molecular Biology Division (HiGenoMB®) says ‘’An early diagnostic tool that would help to differentiate between Flu and Covid-19 was the need of the hour. Time is of essence; this kit can give results in a short span, enabling rapid and appropriate detection that could help in early diagnosis & treatment.

Please visit our website www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.

About HiMedia Laboratories Pvt. Ltd.

HiMedia is one of the largest Indian Biosciences company, providing solutions to over 150 countries worldwide with an all-inclusive product range catering to Microbiology, Molecular Biology, Animal Cell culture, Plant Tissue culture, Bio chemicals, Laboratory Aids, Molecular Diagnostic instruments and more.

HiGenoMB® encompasses the Molecular Biology Product Range of HiMedia Laboratories Pvt. Ltd. Comprising of DNA/RNA Extraction kits, PCR reagents, NASBA (Nucleic Acid Sequence Based Amplification tests), Proteomics, Molecular biology grade chemicals and buffers and Instrumentation for Research & Diagnostics.

HiGenoMB® has now ventured into service industry with its Hi-Gx360TM services offering a complete portfolio of Sequencing & Bioinformatics solutions in diverse areas. Covering major aspects of the most dynamic branches of the Life Sciences group, HiGenoMB® team strives hard to make molecular work enjoyable with its user friendly product range.

Follow us on Google News

What are some great free online tools for entrepreneurs?

How To Earn Money Through Google Blogger?

What is the difference between Mutual Funds and Stocks?

Get Productive! Top Google Docs Features Explained

What is a business plan?